Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
NovaBay Pharmaceuticals (NBY) Q3 2024 Earnings
NBY
13
Aug
Confirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
-5.25
-3.62
-2
-0.37
Details
Expected EPS
-1.225
Actual EPS
-1.37
Surprise EPS
-0.15
Surprise Percent
+11.84%
Description
NovaBay Pharmaceuticals (NBY) has reported earnings of -1.37 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login